NextWave Pharmaceuticals has launched Nexiclon XR (clonidine extended-release), a once daily dosing of clonidine in both suspension and tablet formulations, for the treatment of hypertension.
Nexiclon XR is a direct-acting alpha 2 adrenergic agonist. Nexiclon XR suspension is available in a 0.09mg/mL strength formulation. Nexiclon XR tablet is available in 0.17mg and 0.26mg dosage strengths.
For more information call (800) 206-8115 or visit www.nexiclonxr.com.